Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of ruxolitinib cream in prurigo nodularis
2019-004739-22Phase 2Completed
- Sponsor
- University of Bonn
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in prurigo nodularis (PN) comparing Ruxolitinib cream with Placebo cream (2 arms). Primary endpoint: Change in numeric rating scale (NRS) for itch. Started Oct 2020; status: completed.
02
Drugs
03
Conditions
prurigo nodularis (PN)
Beyond the preview
Go deeper on 2019-004739-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004739-22.